Journal of Cancer Therapy
Vol.10 No.1(2019), Paper ID 89712, 20
pages
DOI:10.4236/jct.2019.101001
Increased Mortality Risk among Early Stage Hormone Receptor Positive Breast Cancer Patients Who Did Not Receive Adjuvant or Neoadjuvant Therapy
Sacha Satram-Hoang, Alisha Stein, Patricia Cortazar, Faiyaz Momin, Carolina Reyes
Q.D. Research, Inc., Granite Bay, CA, USA
Genentech, Inc., South San Francisco, CA, USA
Genentech, Inc., South San Francisco, CA, USA
Q.D. Research, Inc., Granite Bay, CA, USA
Genentech, Inc., South San Francisco, CA, USA
Copyright © 2019 Sacha Satram-Hoang, Alisha Stein, Patricia Cortazar, Faiyaz Momin, Carolina Reyes et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Satram-Hoang, S. , Stein, A. , Cortazar, P. , Momin, F. and Reyes, C. (2019) Increased Mortality Risk among Early Stage Hormone Receptor Positive Breast Cancer Patients Who Did Not Receive Adjuvant or Neoadjuvant Therapy.
Journal of Cancer Therapy,
10, 1-20. doi:
10.4236/jct.2019.101001.